您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Bausch Health Companies
LEI B3BS7ACMDUWISF18KY76, Swift码 BHCNCA8VXXX

此发行人的债券于2016年记录违约情况
机构名称
Bausch Health Companies Inc.
国家名称
加拿大
注册登记国
加拿大
行业
药品生产和生物技术
债券负债
11.751 百万 USD

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

最新数据在

卖价

查询已发送
无法访问
信息提供者所提供的报价仅供参考。

简介

Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc., before Biovail Corporation) is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments: U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. On December 12, 2011, it acquired assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. (Janssen). On December 16, 2011, it acquired the dermatology business, Dermik, of Sanofi. On December 21, 2011, it acquired iNova, from Archer Capital, Ironbridge Capital and other minority management shareholders. On February 1, 2012, it acquired Probiotica Laboratorios Ltda. On February 3, 2012, it divested 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), and 5% fluorouracil cream, (5-FU). On March 12, 2012, it acquired a 19.9% interest in Pele Nova Biotecnologia S.A. In April 2012, it acquired Pedinol Pharmacal, Inc.

奖项

相关文件

关联机构

显示所有 隐藏

股票

最近一次的发行

债券负债 (按货币)

代码

  • LEI
    B3BS7ACMDUWISF18KY76
  • Swift码
    BHCNCA8VXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4.500 Health Care
  • CIK
    0000885590
  • EIN
    98-0448205

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权